Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T13:30:33.397Z.
Calculation as of: 2026-10-06T13:30:33.397Z.
Quote observation: 2026-10-06T13:30:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: adca945f375d0863f0f013440b023eebfab0caffb47005764e85a23fe93f72ce
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2018-09-04.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
EBITDA YIELD AVG TTM
N/A
EBITDA YIELD AVG 3Y
N/A
EBITDA YIELD AVG 5Y
N/A
EBITDA YIELD AVG 10Y
N/A
EBITDA YIELD AVG 15Y
N/A
EBITDA YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Aquestive Therapeutics, Inc.
Market Cap
$579.66M
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$583.37M
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$568.20M
EBITDA Yield
N/A
TTM Avg
31.68%
3Y Avg
26.65%
5Y Avg
26.65%
Market Cap
$598.37M
EBITDA Yield
25.97%
TTM Avg
14.91%
3Y Avg
12.56%
5Y Avg
12.68%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | $579.66M | N/A | N/A | N/A | N/A |
| CorMedix Inc. (CRMD)vs › | $578.97M | 53.93% | 22.76% | 17.21% | 17.21% |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $583.37M | N/A | N/A | N/A | N/A |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $589.38M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $568.20M | N/A | 31.68% | 26.65% | 26.65% |
| OrthoPediatrics Corp. (KIDS)vs › | $595.38M | N/A | N/A | N/A | N/A |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $598.37M | 25.97% | 14.91% | 12.56% | 12.68% |
| Immix Biopharma, Inc. (IMMX)vs › | $554.90M | N/A | N/A | N/A | N/A |
| Delcath Systems, Inc. (DCTH)vs › | $549.24M | N/A | 1.23% | 1.23% | 1.23% |
| Crescent Biopharma, Inc. (CBIO)vs › | $548.99M | N/A | N/A | N/A | N/A |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA YIELD |
|---|---|
| 2018-09-04 | 2.13% |
| 2018-08-31 | 2.11% |
| 2018-08-30 | 2.21% |
| 2018-08-29 | 2.24% |
| 2018-08-28 | 2.35% |
| 2018-08-27 | 2.42% |
| 2018-08-24 | 2.39% |
| 2018-08-23 | 2.37% |
| 2018-08-22 | 2.36% |
| 2018-08-21 | 2.38% |
| 2018-08-20 | 2.36% |
| 2018-08-17 | 2.36% |
| 2018-08-16 | 2.34% |
| 2018-08-15 | 2.30% |
| 2018-08-14 | 2.29% |
| 2018-08-13 | 2.33% |
| 2018-08-10 | 2.40% |
| 2018-08-09 | 2.49% |
| 2018-08-08 | 2.49% |
| 2018-08-07 | 2.50% |
| 2018-08-06 | 2.50% |
| 2018-08-03 | 2.50% |
| 2018-08-02 | 2.50% |
| 2018-08-01 | 2.48% |
| 2018-07-31 | 2.49% |
| 2018-07-30 | 2.49% |
| 2018-07-27 | 2.47% |
| 2018-07-26 | 2.38% |
| 2018-07-25 | 2.35% |
